Diabetes Kongress 2022
Kalender
Liste
Personen
Favoriten
zur Liste
Dr. Sebastian Barth
IQVIA Commercial GmbH & Co. OHG
Germany
Vortrag
Changes of Glucagonlike Peptide-1 Receptor Agonist (GLP-1 RA) and Sodium-glucose Co-transporter 2 Inhibitor (SGLT2i) prescription rates in Germany after the ADA/EASD Consensus Report: A Retrospective Study
Speaker
Datum: 27.05.2022 , Zeit: 11:26
|
Thema: Poster
Details
